National Plan for Epilepsy Act

1. 01

   How should the federal government balance epilepsy research funding against other neurological conditions with similar or larger patient populations?

2. 02

   What specific metrics or milestones would indicate whether this national plan has meaningfully improved diagnosis and treatment outcomes for epilepsy patients?

3. 03

   Which stakeholders—patients, researchers, pharmaceutical companies, or states—should have decision-making authority in developing and implementing this coordinated federal plan?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.